Click Here For No Down Payment Medical Practice Financing for medical doctor practice start-ups and practice acquisitions!
Call: 904-551-6090
It is our deep understanding that you have very unique needs that are diverse from the rest the clients who want to have their own medical practice centers. We have set up systems in our company that will ensure that you get custom services that will meet your needs. Through this you will be able to attain the proper financial package. The attaining of the set company goals will hence be easy with the excellent medical practice loans start up company system.
Read The Interesting Snippets Below For Exciting Health-Care News!
AUSTIN, Texas, April 30 (Reuters) – Firing squads, electric chairs and other methods of execution seen as cruel or antiquated could be getting a fresh look after Oklahoma botched a lethal injection, leaving the condemned inmate withering in apparent pain on its death chamber gurney.
Incorrect biopsy results cloud Nymox Pharma prostate cancer study
– http://www.reuters.com/healthNews
(Reuters) – Nymox Pharmaceutical Corp said its experimental prostate cancer drug reduced the progression of cancer in patients, but it could not determine if the study succeeded in meeting pre-determined goals due to a high rate of incorrect biopsies.
(Reuters) – Johnson & Johnson suspended worldwide sale of its device used in fibroid surgery amid concerns over its potential to spread undetected cancer beyond the uterus.
LONDON (Reuters) – The spread of deadly superbugs that evade even the most powerful antibiotics is no longer a prediction but is happening right now across the world, United Nations officials said on Wednesday.
LONDON (Reuters) – Leading British scientists called on the government on Wednesday to act now to save the nation’s pharmaceutical industry from being swallowed up in a wave of consolidation driven by overseas rivals.
Exclusive: Sanofi explores $7 billion-plus drug divestiture – sources
– http://www.reuters.com/healthNews
LONDON/NEW YORK (Reuters) – Sanofi SA is looking to sell a portfolio of mature drugs that could fetch between $7 billion and $8 billion, according to people familiar with the matter, yet another example of drugmakers trying to shed non-core assets and focus on high-growth areas.
Medical Practice Loans!
No down payment medical, dental and healthcare provider practice financing here! + More News: J&J suspends sale of device used in fibroid surgery + MORE 05/01/2014
No comments:
Post a Comment